Offshore refresher: live and learn

PSA’s Offshore Refresher Conference this year took members to Europe. ECP Sinead Stone MPS went along, courtesy of a grant from Bayer. It was...

National Diabetes Week: now is the time to help people stay...

ADVERTORIAL BY GLUCERNA® It can be challenging for those with impaired glucose tolerance or insulin resistance to maintain a healthy, low GI diet; especially considering...

An innovative, effective OTC solution to scalp pruritus

Dermal Therapy’s Scalp Relief range is clinically proven to relieve scalp itch and irritation in minutes. It is steroid- and tar-free and targets multiple common causes of itchy scalp.

Treating hypertension – a new approach

Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

PSA’s projects make a bigger impact than ever before

The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.

‘Devastating’ volume of clinical waste generates concern

As environmental threats become increasingly pressing, healthcare professionals are calling for changes in the way clinical waste is managed in medical settings. In a recent...